Pharmafile Logo
Pharmafocus logo
Advanced Search

PharmAla receives MDMA research grant from Ontario Centre of Innovation

June 12, 2023
Research and Development MDMA, PharmAla, Psychiatry, in silico, research grant

Canadian biotechnology company PharmAla has announced that it has been awarded a research grant from the Ontario Centre of Innovation …

News
kidney

Novartis acquires Chinook Therapeutics for $3.5bn

June 12, 2023
Mergers and Acquisitions Chinook Therapeutics, Nephrology, Novartis, kidney disease, pharma

Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based biopharmaceutical company Chinook Therapeutics for …

News

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

June 9, 2023
Research and Development AstraZeneca, Cancer, MSD, NICE, Oncology, lynparza, pharma

UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) posted a positive recommendation …

News
acute_lymphoblastic_leukaemia_smear

Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib

June 9, 2023
Research and Development Astellas Pharma, BMT CTN, Haematology, gilteritinib, leukaemia, pharmaceutical

Japanese pharmaceutical company Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) have presented their phase …

News
blood_tests_pic

Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

June 8, 2023
Research and Development Cancer, FDA, Haematology, Innate Pharma, Sanofi, haematology

Innate Pharma has announced that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …

News

Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients

June 8, 2023
Medical Education Echosens, Hepatology, Inventiva, liver disease, nash, non-alcoholic steatohepatitis

French clinical stage biopharmaceutical company Inventiva has announced a collaboration with US-based high-technology company Echosens to bring attention to, and …

News

Inizio launches strategic engagement offering to transform customer experiences

June 7, 2023
Business Services Inizio, Inizio Engage, commercialisation

6 June 2023 – London, UK — Inizio, a global commercialisation partner dedicated to the health and life sciences industry, …

News
Press release
glsun-mall-9xmv81sz5fw-unsplash

Fosun Pharma and IFC partner to improve access to medicines in Africa

June 7, 2023
Manufacturing and Production Africa, Fosun Pharma, IFC, Infections and infestations, manufacturing

Shanghai Fosun Pharmaceutical Group has announced a partnership with the International Finance Corporation (IFC) with the aim of helping the …

News
1200px-vaccine_image_1

GSK’s RSV vaccine approved in EU for older adults

June 7, 2023
Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine

GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial virus (RSV) vaccine for active …

News
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631

Axol Bioscience and StrataStem collaborate to deliver ‘clinical trial in a dish’ for Alzheimer’s disease

June 7, 2023
Research and Development Alzheimer's, Axol Bioscience, Neurology, StrataStem

Pluripotent stem cell technology provider Axol Bioscience has signed an exclusive agreement with UK-based StrataStem to access and commercialise its …

News
weight-2036971_960_720

UK plans £40m drug trial for Novo Nordisk’s Wegovy to aid NHS in treating obesity

June 7, 2023
Research and Development NHS, Novo Nordisk, Obesity, Wegovy, clinical trial, obesity

The UK Government has announced plans to launch a pilot programme which will provide GPs with Novo Nordisk’s Wegovy (semaglutide), …

News
blood_tests_pic

GRAIL and University of Oxford showcase first prospective study results for multi-cancer early detection test

June 6, 2023
Research and Development Cancer, GRAIL, Oncology, University of Oxford, cancer testing

US-based healthcare company GRAIL and the University of Oxford, UK, have announced encouraging first prospective study results at the American …

News

ISA Pharmaceuticals highlights positive clinical data at ASCO

June 6, 2023
Research and Development ASCO, Cancer, HPV, ISA Pharmaceuticals, Oncology

Clinical stage biotechnology company ISA Pharmaceuticals has announced positive phase 1 data at the American Society of Clinical Oncology (ASCO) …

News

Bellerophon shares top-line data from phase 3 trial of INOpulse for fILD

June 6, 2023
Medical Communications Bellerophon Therapeutics, Cardiology, clinical trials, fibrotic interstitial lung disease

Bellerophon Therapeutics has announced top-line results from its phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for …

News

GSK receives FDA file acceptance for Jemperli plus chemotherapy for treating endometrial cancer

June 6, 2023
Research and Development GSK, Jemperli, Oncology, endometrial cancer, oncology

GSK has announced that the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for …

News

AstraZeneca’s phase 4 trial stopped early after reaching pre-specified criteria

June 5, 2023
Research and Development ANNEXA-I, Andexxa, AstraZeneca, Neurology, clinical trial

AstraZeneca has announced that its post-marketing phase 4 ANNEXA-I trial has been stopped early after reaching its pre-specified stopping criteria. …

News

Quanticate announces strategic partnership with KPS Life

June 5, 2023
Medical Communications KPS Life, Pharmacy, Quanticate, fsp

Global biometric clinical research group Quanticate has announced a strategic partnership with US-based provider of functional service provision (FSP) solutions …

News

Allogene Therapeutics shares updated ALLO-501/501A phase 1 data in large B-cell lymphoma at ASCO annual meeting

June 5, 2023
Research and Development Allogene, LBCL, Oncology, lymphoma, oncology

Allogene Therapeutics has shared updated data from the phase 1 ALPHA/ALPHA2 trials of ALLO-501/501A in patients with relapsed/refractory (r/r) large …

News

Report finds NHS may miss out on new drugs due to rising costs

June 5, 2023
Sales and Marketing LSE, LSHTM, NHS, Pharmacy, University of York, drug prices

Figures from a team at the University of York, the London School of Economics and Political Science (LSE) and the …

News

NICE approves first treatment for obstructive HCM for NHS use

June 2, 2023
Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM

The National Institute for Health and Care Excellence (NICE) has announced that it has approved mavacamten (Camzyos) for the treatment …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025